Demonstration of antiallodynic effects of the cyclooxygenase-2 inhibitor meloxicam on established diabetic neuropathic pain in mice

Journal of Pharmacological Sciences

Volumn 110, Issue 2, 2009, Pages 213-217

  Kimura, Satoko ^a   Kontani, Hitoshi ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

Antiallodynic effect; Cyclooxygenase 2 (COX 2) inhibitor; Diabetic neuropathic pain

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; MELOXICAM;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DRUG ACTIVITY; MALE; MOUSE; NERVE FIBER; NEUROPATHIC PAIN; NONHUMAN; PAIN THRESHOLD;

EID: 67649657674     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09006SC     Document Type: Article

References (16)

1. Schaible HG, Ebersberger A, Von Banchet GS. Mechanisms of pain in arthritis. Ann N Y Acad Sci. 2002;966:343-354. (Pubitemid 34729193)
2. Freshwater JD, Svensson CI, Malmberg AB, Calcutt NA. Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats. Diabetes. 2002;51:2249-2255. (Pubitemid 34729032)
3. Kellogg AP, Wiggin TD, Larkin DD, Hayes JM, Stevens MJ, Pop-Busui R. Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intra-epidermal nerve fiber loss in experimental diabetes. Diabetes. 2007;56:2997-3005. (Pubitemid 350223635)
4. Matsunaga A, Kawamoto M, Shiraishi S, Yasuda T, Kajiyama S, Kurita S, et al. Intrathecally administered COX-2 but not COX-1 or COX-3 inhibitors attenuate streptozotocin-induced mechanical hyperalgesia in rats. Eur J Pharmacol. 2007;554:12-17. (Pubitemid 44820041)
5. Bujalska M, Tatarkiewicz J, de Cordé A, Gumulka SW. Effect of cyclooxygenase and nitric oxide synthase inhibitors on streptozotocin-induced hyperalgesia in rats. Pharmacology. 2008;81:151-157. (Pubitemid 351182690)
6. Noble S, Balfour JA. Meloxicam. Drugs. 1996;51:424-430; discussion 431-432.
7. Takeda K, Sawamura S, Tamai H, Sekiyama H, Hanaoka K. Role for cyclooxygenase 2 in the development and maintenance of neuropathic pain and spinal glial activation. Anesthesiology. 2005;103:837-844. (Pubitemid 41415533)
8. Dixon WJ. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol. 1980;20:441-462.
9. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53:55-63. (Pubitemid 24238751)
10. Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 1990;43:205-218. (Pubitemid 20385185)
11. Hylden JL, Wilcox GL. Intrathecal morphine in mice: a new technique. Eur J Pharmacol. 1980;67:313-316. (Pubitemid 10007057)
12. Thalhammer JG, Vladimirova M, Bershadsky B, Strichartz GR. Neurologic evaluation of the rat during sciatic nerve block with lidocaine. Anesthesiology. 1995;82:1013-1025.
13. Marnett LJ, Kalgutkar AS. Design of selective inhibitors of cyclooxygenase-2 as nonulcerogenic anti-inflammatory agents. Curr Opin Chem Biol. 1998;2:482-490. (Pubitemid 128645701)
14. Busch U, Schmid J, Heinzel G, Schmaus H, Baierl J, Huber C, et al. Pharmacokinetics of meloxicam in animals and the relevance to humans. Drug Metab Dispos. 1998;26:576-584. (Pubitemid 28498364)
15. Davis A, Perkins MN. The effect of capsaicin and conventional analgesics in two models of monoarthritis in the rat. Agents Actions. 1993;38 Spec No:C10-12.
16. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A. 1999;96:7563-7568. (Pubitemid 29299702)